Raphas (214260) Stock Overview

Raphas Co., Ltd. provides skin-based drug delivery systems in South Korea, Japan, and China. The company offers cosmetics under the Acropass brand. It also provides original design manufacturer services in producing cosmetics for various needs, such as wrinkle reduction, freckle, and acne treatment; and medical contract manufacturing services. The company was founded in 2006 and is headquartered in Seoul, South Korea.